Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001673232-25-000013

PRESIDENT AND COO sold 22,500 shares at $473.66 ($10,657,280)

  • PRESIDENT AND COO acquired 22,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENKOWITZ MICHAEL · PRESIDENT AND COO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-24 Exercise or conversion : show line 1 in the form 10b5-1 +2,625 $117.76 $309,120 2,625 I
2025-11-24 Sale : show line 2 in the form 10b5-1 −2,625 $473.66 $1,243,349 0 I
2025-11-24 Exercise or conversion : show line 3 in the form 10b5-1 +12,000 $135.42 $1,625,040 12,000 I
2025-11-24 Sale : show line 4 in the form 10b5-1 −12,000 $473.66 $5,683,883 0 I
2025-11-24 Exercise or conversion : show line 5 in the form 10b5-1 +7,875 $146.03 $1,149,986 7,875 I
2025-11-24 Sale : show line 6 in the form 10b5-1 −7,875 $473.66 $3,730,048 0 I
Open-market sales · 22,500 sh · avg $473.66 · $10,657,280

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-11-24 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option −12,000 $135.42 2027-03-15 12,000 0 I
2025-11-24 Exercise or conversion : show line 8 in the form 10b5-1 Stock Options −2,625 $117.76 2027-03-15 2,625 184,875 I
2025-11-24 Exercise or conversion : show line 9 in the form 10b5-1 Stock Options −7,875 $146.03 2027-03-15 7,875 29,815 I
Loading xslF345X05/primarydocument.xml…